Lerner Research Institute News

Read about the latest advances from Lerner Research Institute scientists, including new findings, grant awards, innovations and collaborations.

VIDEO: New Center for Immunotherapy and Precision Immuno-Oncology to Help Advance Head and Neck Cancer Research

Researchers from the new Center for Immunotherapy and Precision Immuno-Oncology will leverage their expertise with Cleveland Clinic’s world-class resources to help advance patient care and research into new therapies related to many cancer types, including head and neck cancers.

09/28/2020

With one of the largest cell production facilities in the state and a robust biorepository, Cleveland Clinic aims to lead the future of head and neck cancer and cancer therapies, including immunotherapies. Cleveland Clinic has made a strong commitment—over $80 million—to fund its new Center for Immunotherapy and Precision Immuno-Oncology (CITI), which will support immunotherapy research and care related to many types of cancers. Hear from Brian Burkey, MD, vice chair of the Head & Neck Institute, and Timothy Chan, MD, PhD, director of CITI, about how the two teams will work together to advance head and neck cancer translational research, with the ultimate goal to enhance patient care and outcomes.

 

 



Looking for more news and updates from Lerner Research Institute? Check out our news archive.

View Archive

Looking for more news and updates from Cleveland Clinic? Check out the Cleveland Clinic Newsroom.

Cleveland Clinic News Feed